Location of Repository

Factors Influencing Retention in Care after Starting Antiretroviral Therapy in a Rural South African Programme

By Tom H. Boyles, Lynne S. Wilkinson, Rory Leisegang and Gary Maartens
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3086905
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (2006). A
    2. Amathole district municipality. Draft Intergrated development plan review 2008–2009.
    3. (1997). Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.
    4. (2007). Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Trans R Soc Trop Med Hyg
    5. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.
    6. (2002). Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.
    7. (2007). Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania.
    8. (2009). Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.
    9. (2010). Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in Lesotho.
    10. (2011). Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.
    11. (1998). Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.
    12. (2005). Efficacy of antiretroviral therapy in resourcepoor settings: are outcomes comparable to those in the developed world?
    13. (2005). Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.
    14. (2008). Electronic medical record systems, data qualit ya n dl o s st of o l l o w - u p :s u r v e yo f antiretroviral therapy programmes in resource-limited settings.
    15. (2008). Five-year outcomes of initial patients treated in Botswana’s National Antiretroviral Treatment Program.
    16. (2010). Grobler A
    17. (1997). Immunological markers in HIV-infected pregnant women
    18. (2010). Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings.
    19. (2010). Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention.
    20. (2008). Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment.
    21. (2007). Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy.
    22. (2004). National Antiretroviral Treatment Guidelines. Pretoria, South Africa: National Dept of Health;
    23. (1994). Neuropsychological and neurological findings.
    24. (2010). Organization. Scaling Up Antiretroviral Therapy in Resourcelimited Settings: Treatment Guidelines for a Public Health Approach. Available: http://whqlibdoc.who.int/publications/2004/9241591552.pdf.
    25. (2004). Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.
    26. (2010). Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health 15 Suppl:
    27. (2010). Postnatal depression by HIV status among women in Zimbabwe.
    28. (2002). Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
    29. (2004). Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa.
    30. (2001). Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    31. (2010). Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
    32. (2001). South Africa Census
    33. (2005). South African National HIV prevalence, HIV incidence, behaviour and communication survey,
    34. (2010). Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa,
    35. (2010). Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors.
    36. (2006). Treatment supporter to improve adherence to antiretroviral therapy in HIVinfected South African adults. A qualitative study.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.